Dr. George F Gwinn M.D.

Recommended Articles

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

• What is a Lung Biopsy?

  A lung biopsy is a medical procedure which involves removal of a small piece of lung tissue to examine it closely under a powerful microscope. Lung biopsy can be done in 4 different ways. However, the method used depends solely on the overall body health and the place of the lung where the sample is...

• New, Promising Cystic Fibrosis Drug Needs Funding

  Canada has the highest rate of cystic fibrosis in the entire world, with approximately 1 in 134 citizens suffering from the disease. However, a recent drug that has been found to be "life changing" for some cystic fibrosis patients is not being funded.Official responseHealth Minister Adrian Dix...

• How Does Pneumonia Develop?

  Pneumonia is a disease that affects the lungs due to an infection caused by bacteria, virus, or fungus. Pneumonia can either affect the left, right, or both lobes of the lungs.Pneumonia is a serious disease affecting people of any age. However, toddlers and young children are more affected by...

• Can Pleurisy Destroy My Lungs?

  What is pleurisy?Pleurisy is the inflammation of the thin pleural membranes that line the lungs.What happens in pleurisy?A thin membrane called the pleura lines your lungs. The pleura are double-layered membranes that line your lungs as well as the inner aspect of the chest wall. Between these...

• The Signs and Symptoms of Pneumonia

  ...